American Society of Hematology 2020 guidelines for management of venous thromboembolism: treatment of deep vein thrombosis and pulmonary embolism
In August 2022, these guidelines were reviewed by an expert work group convened by ASH.
Review included limited searches for new evidence and discussion of the search results …
Review included limited searches for new evidence and discussion of the search results …
Antithrombotic therapy for VTE disease: second update of the CHEST guideline and expert panel report
Background This is the 2nd update to the 9th edition of these guidelines. We provide
recommendations on 17 PICO (Population, Intervention, Comparator, Outcome) questions …
recommendations on 17 PICO (Population, Intervention, Comparator, Outcome) questions …
Antithrombotic therapy for VTE disease: CHEST guideline and expert panel report
Background We update recommendations on 12 topics that were in the 9th edition of these
guidelines, and address 3 new topics. Methods We generate strong (Grade 1) and weak …
guidelines, and address 3 new topics. Methods We generate strong (Grade 1) and weak …
Venous thromboembolism: advances in diagnosis and treatment
Importance Venous thromboembolism (VTE), comprising deep vein thrombosis (DVT) and
pulmonary embolism (PE), is a common and potentially fatal disease. Objective To …
pulmonary embolism (PE), is a common and potentially fatal disease. Objective To …
Interventional therapies for acute pulmonary embolism: current status and principles for the development of novel evidence: a scientific statement from the American …
Pulmonary embolism (PE) represents the third leading cause of cardiovascular mortality.
The technological landscape for management of acute intermediate-and high-risk PE is …
The technological landscape for management of acute intermediate-and high-risk PE is …
Thrombolysis for pulmonary embolism and risk of all-cause mortality, major bleeding, and intracranial hemorrhage: a meta-analysis
S Chatterjee, A Chakraborty, I Weinberg, M Kadakia… - Jama, 2014 - jamanetwork.com
Importance Thrombolytic therapy may be beneficial in the treatment of some patients with
pulmonary embolism. To date, no analysis has had adequate statistical power to determine …
pulmonary embolism. To date, no analysis has had adequate statistical power to determine …
Pulmonary embolism: update on management and controversies
L Duffett, LA Castellucci, MA Forgie - Bmj, 2020 - bmj.com
Pulmonary embolism is a common and potentially fatal cardiovascular disorder that must be
promptly diagnosed and treated. The diagnosis, risk assessment, and management of …
promptly diagnosed and treated. The diagnosis, risk assessment, and management of …
Antithrombotic therapy for VTE disease: antithrombotic therapy and prevention of thrombosis: American College of Chest Physicians evidence-based clinical practice …
Background This article addresses the treatment of VTE disease. Methods We generated
strong (Grade 1) and weak (Grade 2) recommendations based on high-quality (Grade A) …
strong (Grade 1) and weak (Grade 2) recommendations based on high-quality (Grade A) …
Systemic thrombolytic therapy for acute pulmonary embolism: a systematic review and meta-analysis
C Marti, G John, S Konstantinides… - European heart …, 2015 - academic.oup.com
Aim Thrombolytic therapy induces faster clot dissolution than anticoagulation in patients with
acute pulmonary embolism (PE) but is associated with an increased risk of haemorrhage …
acute pulmonary embolism (PE) but is associated with an increased risk of haemorrhage …